Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/13/2012CA2326959C Treatments for spinal muscular atrophy
03/13/2012CA2256308C Antibodies to the ed-b domain of fibronectin, their construction and uses
03/13/2012CA2238080C A novel haemopoietin receptor and genetic sequences encoding same
03/13/2012CA2208524C Delivery of nucleic acid molecules to mucosal tissue
03/13/2012CA2195955C Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
03/13/2012CA2191220C Cdna for human methylenetetrahydrofolate reductase
03/08/2012WO2012031298A2 Ethynylbenzene derivatives
03/08/2012WO2012031252A1 High dose buprenorphine compositions and use as analgesic
03/08/2012WO2012031245A1 Biodegradable liquogel and ph sensitive nanocarriers
03/08/2012WO2012031237A1 Fused tricyclic ether carbamates and their use
03/08/2012WO2012031220A2 Nicotine compounds and analogs thereof, synthetic methods of making compounds, and methods of use
03/08/2012WO2012031199A1 Guanidine compounds and compositions for the inhibition of nampt
03/08/2012WO2012031197A1 Novel compounds and compositions for the inhibition of nampt
03/08/2012WO2012031196A1 4- { [ ( pyridin- 3 - yl -methyl) aminocarbonyl] amino} benzene - sulfone derivatives as nampt inhibitors for therapy of diseases such as cancer
03/08/2012WO2012031186A1 Prebiotic suppositories
03/08/2012WO2012031175A2 Nanoparticle-based tumor-targeted drug delivery
03/08/2012WO2012031138A2 Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purine-2,6(3h,7h)dione
03/08/2012WO2012031137A2 Vesicular stomatitis viruses
03/08/2012WO2012031125A2 Reversal of general anesthesia by administration of methylphenidate, amphetamine, modafinil, amantadine, and/or caffeine
03/08/2012WO2012031124A2 Drug formulations using water soluble antioxidants
03/08/2012WO2012031123A2 Method of treating ear infections
03/08/2012WO2012031118A2 Cell permeable inhibitors of anaphase promoting complex
03/08/2012WO2012031090A2 Small molecule inhibitors of ebola and lassa fever viruses and methods of use
03/08/2012WO2012031057A1 Bms- 582949 for the treatment of resistant rheumatic disease
03/08/2012WO2012031045A2 Phosphonate ester derivatives and methods of synthesis thereof
03/08/2012WO2012031028A2 Methods for treating neurodegenerative diseases
03/08/2012WO2012031024A1 Bicyclic oxazole and thiazole compounds and their use as allosteric modulators of mglur5 receptors
03/08/2012WO2012031018A1 Methods and formulations of treating thrombosis with betrixaban and a p-glycoprotein inhibitor
03/08/2012WO2012031017A1 CRYSTALLINE FORMS OF A FACTOR Xa INHIBITOR
03/08/2012WO2012031004A1 Pyridinones/pyrazinones, method of making, and method of use thereof
03/08/2012WO2012030993A2 Skin compositions and methods of use thereof
03/08/2012WO2012030990A1 Pyridazinones, method of making, and method of use thereof
03/08/2012WO2012030984A2 Skin compositions and methods of use thereof
03/08/2012WO2012030953A1 5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level
03/08/2012WO2012030951A1 Fast-dissolve dosage forms of 5-ht2c agonists
03/08/2012WO2012030948A1 Quinazoline compounds and methods of use thereof
03/08/2012WO2012030944A2 Quinoline and isoquinoline compounds and methods of use thereof
03/08/2012WO2012030939A1 Administration of lorcaserin to individuals with renal impairment
03/08/2012WO2012030938A1 Salts of lorcaserin with optically active acids
03/08/2012WO2012030927A2 Modified-release dosage forms of 5-ht2c agonists useful for weight management
03/08/2012WO2012030924A1 Azolopyridine and azolopyrimidine compounds and methods of use thereof
03/08/2012WO2012030919A2 Composition and method for muscle repair and regeneration
03/08/2012WO2012030918A1 Adenosine a3 receptor modulating compounds and methods of use thereof
03/08/2012WO2012030917A1 An optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
03/08/2012WO2012030914A1 4-azolylaminoquinazoline derivatives and methods of use thereof
03/08/2012WO2012030913A1 An optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
03/08/2012WO2012030912A1 7-cyclylquinazoline derivatives and methods of use thereof
03/08/2012WO2012030910A1 2-cycloquinazoline derivatives and methods of use thereof
03/08/2012WO2012030907A1 Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
03/08/2012WO2012030896A2 Methods for treatment of non-small cell lung cancer
03/08/2012WO2012030894A1 Thienopyridine and thienopyrimidine compounds and methods of use thereof
03/08/2012WO2012030886A1 Combination of hdac inhibitors with thrombocytopenia drugs
03/08/2012WO2012030885A1 Hydrobromide salts of a pyrazolylaminoquinazoline
03/08/2012WO2012030745A1 MULTIVITAMIN TARGETING OF RNAi THERAPEUTICS
03/08/2012WO2012030716A1 Pharmaceutical preparations for treatments of diseases and disorders of the breast
03/08/2012WO2012030685A2 Indazole derivatives useful as erk inhibitors
03/08/2012WO2012030681A1 Pesticidal compositions
03/08/2012WO2012030664A1 Dry powder formulations and methods for treating pulmonary diseases
03/08/2012WO2012030647A1 Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
03/08/2012WO2012030645A1 Respirably dry powder comprising calcium lactate, sodium chloride and leucine
03/08/2012WO2012030633A1 Tyrosine kinase inhibitors
03/08/2012WO2012030626A2 Design of oligonucleotide analogs as therapeutic agents
03/08/2012WO2012030513A2 Methods of treating bacterial infections through pulmonary delivery of fusidic acid
03/08/2012WO2012030408A1 Compounds and compositions for treating cancer
03/08/2012WO2012030314A1 Compositions comprising 5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine, and methods of administering same
03/08/2012WO2012030309A2 Formulation of calcium channel blocker
03/08/2012WO2012030302A1 Tyrosine-phosphorylated wbp2, a novel cancer target and biomarker
03/08/2012WO2012030258A1 Heterocyclic low-molecular sapp mimetics, a pharmaceutical composition and methods for producing and using same
03/08/2012WO2012030234A1 Methods and compositions for treating cancer
03/08/2012WO2012030231A1 Antifungal composition
03/08/2012WO2012030208A1 Method and preparation for the treatment or prevention of anxiety or neurogenesis
03/08/2012WO2012030170A2 Novel compound acting as a cannabinoid receptor-1 inhibitor
03/08/2012WO2012030165A2 Use of the fetal reprogramming of a ppar δ agonist
03/08/2012WO2012030160A2 Quinoline or quinazoline derivatives with apoptosis inducing activity on cells
03/08/2012WO2012030106A2 Production method of intermediate compound for synthesizing medicament
03/08/2012WO2012030050A2 Pharmaceutical composition for prevention or treatment of degenerative neurological brain disorders
03/08/2012WO2012030030A1 Chitosan derivative of a type cured by visible light and a use for the same as a medical raw material
03/08/2012WO2012029994A1 Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis
03/08/2012WO2012029991A1 Fused triazoles for the treatment or prophylaxis of mild cognitive impairment
03/08/2012WO2012029986A1 Antisense nucleic acid
03/08/2012WO2012029942A1 Cyclic amide derivative
03/08/2012WO2012029913A1 Oral preparation
03/08/2012WO2012029898A1 Mitigating agent for alcohol-induced problems
03/08/2012WO2012029870A1 Oligonucleotide, and therapeutic agent for dyslipidemia containing oligonucleotide as active ingredient
03/08/2012WO2012029863A1 Sulfated polysaccharide capable of binding to growth factor and use thereof
03/08/2012WO2012029836A1 Method for producing 1-triazole-2-butanol derivative
03/08/2012WO2012029827A1 Process for producing drug—block-copolymer composite and pharmaceutical product containing same
03/08/2012WO2012029771A1 Tumor proliferation inhibitor containing ultrasound-sensitive substance and method for inhibiting tumor proliferation using tumor proliferation inhibitor and low-intensity pulsed ultrasound
03/08/2012WO2012029722A1 Screening method
03/08/2012WO2012029672A1 Noxious organism control agent
03/08/2012WO2012029655A1 Agent for controlling hemodialysis-induced cramps
03/08/2012WO2012029609A1 Compound having silicon-containing substituent introduced thereto, and singlet oxygen-generating agent and cancer therapeutic comprising same
03/08/2012WO2012029456A1 Oil-in-water emulsion composition containing poorly-soluble drug, and method for manufacturing same
03/08/2012WO2012029348A1 Granules containing bitter drug and orally disintegrating tablet
03/08/2012WO2012029326A1 3-pyrazolyl-2-pyridone derivative
03/08/2012WO2012029200A1 Orally administered composition having effect of improving serum lipids, and food/beverage composition
03/08/2012WO2012029160A1 Stabilized polyphenol solution and method for stabilizing polyphenol solution
03/08/2012WO2012029097A1 Transdermal preparation
03/08/2012WO2012029074A2 Pharmaceutical compositions of linezolid
03/08/2012WO2012029070A1 Heterocyclyl compounds as histamine h3 receptor ligands
1 ... 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 ... 7860